Literature DB >> 8698101

Inhibition of invasion and intraerythrocytic development of Plasmodium falciparum by kinase inhibitors.

A R Dluzewski1, C R Garcia.   

Abstract

We have examined the effects of seven protein kinase inhibitors (staurosporine, genistein, methyl 2,5-dihydroxycinnamate, tyrphostins B44 and B46, lavendustin A and R03) on the erythrocytic cycle of the malaria parasite, Plasmodium falciparum. One (staurosporine) strongly inhibits serine/threonine kinases, but the remainder all exhibit a strong preference for tyrosine kinases. We have been able to discriminate between effects on invasion and on intraerythrocytic development. All reagents impeded development of intraerythrocytic parasites, though at widely differing concentrations, from the sub-micromolar to the millimolar. Several inhibitors, including staurosporine, also reduced invasion. The phosphatase inhibitor, okadaic acid, had a strong inhibitory effect both on invasion and development. The regulation of malaria development by phosphorylation or dephosphorylation reactions at several points in the blood-stage cycle is implied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698101     DOI: 10.1007/bf01969742

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  15 in total

1.  Localization and stage specific phosphorylation of Plasmodium falciparum phosphoproteins during the intraerythrocytic cycle.

Authors:  B W Suetterlin; B Kappes; R M Franklin
Journal:  Mol Biochem Parasitol       Date:  1991-05       Impact factor: 1.759

2.  Cyclic AMP- and Ca2(+)-dependent protein kinases in Plasmodium falciparum.

Authors:  L K Read; R B Mikkelsen
Journal:  Exp Parasitol       Date:  1990-07       Impact factor: 2.011

Review 3.  Vesicle-mediated transport of membrane and proteins in malaria-infected erythrocytes.

Authors:  J W Barnwell
Journal:  Blood Cells       Date:  1990

Review 4.  Okadaic acid: a new probe for the study of cellular regulation.

Authors:  P Cohen; C F Holmes; Y Tsukitani
Journal:  Trends Biochem Sci       Date:  1990-03       Impact factor: 13.807

5.  Plasmodium falciparum calcium-dependent protein kinase phosphorylates proteins of the host erythrocytic membrane.

Authors:  Y Zhao; R M Franklin; B Kappes
Journal:  Mol Biochem Parasitol       Date:  1994-08       Impact factor: 1.759

6.  Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells.

Authors:  A H Chishti; G J Maalouf; S Marfatia; J Palek; W Wang; D Fisher; S C Liu
Journal:  Blood       Date:  1994-06-01       Impact factor: 22.113

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

9.  A plasmodium protein kinase that is developmentally regulated, stimulated by spermine, and inhibited by quercetin.

Authors:  M F Wiser; J W Eaton; J R Sheppard
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

10.  A simple method for isolating viable mature parasites of Plasmodium falciparum from cultures.

Authors:  A R Dluzewski; I T Ling; K Rangachari; P A Bates; R J Wilson
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

View more
  15 in total

1.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Authors:  X Chen; H Zhou; Y B Liu; J F Wang; H Li; C Y Ung; L Y Han; Z W Cao; Y Z Chen
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

2.  Expression and biochemical characterization of the Plasmodium falciparum protein kinase A catalytic subunit.

Authors:  Nathalie Wurtz; Boris Pastorino; Lionel Almeras; Sébastien Briolant; Claude Villard; Daniel Parzy
Journal:  Parasitol Res       Date:  2009-01-22       Impact factor: 2.289

3.  In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans.

Authors:  M Ouarzane-Amara; J F Franetich; D Mazier; G R Pettit; L Meijer; C Doerig; I Desportes-Livage
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.

Authors:  Rajshekhar Y Gaji; Lisa Checkley; Michael L Reese; Michael T Ferdig; Gustavo Arrizabalaga
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Phenotypic and transcriptomic analyses of Plasmodium falciparum protein kinase A catalytic subunit inhibition.

Authors:  Nathalie Wurtz; Jérôme Desplans; Daniel Parzy
Journal:  Parasitol Res       Date:  2009-09-25       Impact factor: 2.289

6.  Cdc42 and the actin-related protein/neural Wiskott-Aldrich syndrome protein network mediate cellular invasion by Cryptosporidium parvum.

Authors:  Xian-Ming Chen; Bing Q Huang; Patrick L Splinter; James D Orth; Daniel D Billadeau; Mark A McNiven; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Characterization of a UBC13 kinase in Plasmodium falciparum.

Authors:  Nisha Philip; Timothy A Haystead
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

8.  The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.

Authors:  Zbynek Bozdech; Manuel Llinás; Brian Lee Pulliam; Edith D Wong; Jingchun Zhu; Joseph L DeRisi
Journal:  PLoS Biol       Date:  2003-08-18       Impact factor: 8.029

9.  The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony.

Authors:  Helen M Taylor; Louisa McRobert; Munira Grainger; Audrey Sicard; Anton R Dluzewski; Christine S Hopp; Anthony A Holder; David A Baker
Journal:  Eukaryot Cell       Date:  2009-11-13

10.  Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo.

Authors:  Aki Ishiyama; Masato Iwatsuki; Rei Hokari; Masaaki Sawa; Satoshi Ōmura; Kazuhiko Otoguro
Journal:  J Antibiot (Tokyo)       Date:  2015-02-18       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.